Kiniksa Pharmaceuticals International, plc Selling, General and Administrative Expense
Kiniksa Pharmaceuticals International, plc (KNSA) reported Selling, General and Administrative Expense of $61.15 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for the quarter ending 2026-03-31 was $61.15M, a 40.48% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for the quarter ending 2025-12-31 was $56.77M, a 40.06% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for the quarter ending 2025-09-30 was $49.10M, a 5.83% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for the quarter ending 2025-06-30 was $46.86M, a 10.54% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for fiscal 2025 was $196.27M, a 16.82% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for fiscal 2024 was $168.01M, a 29.81% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for fiscal 2023 was $129.43M, a 32.13% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc selling, general and administrative expense for fiscal 2022 was $97.95M, a 13.97% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $61.15M 10-Q · filed 2026-04-28 | $117.93M derived: sum of 2 quarters · filed 2026-04-28 | $167.03M derived: sum of 3 quarters · filed 2026-04-28 | $213.89M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $56.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $105.88M derived: sum of 2 quarters · filed 2026-02-24 | $152.74M derived: sum of 3 quarters · filed 2026-02-24 | $196.27M 10-K · filed 2026-02-24 |
| 2025-09-30 | $49.10M 10-Q · filed 2025-10-28 | $95.97M derived: sum of 2 quarters · filed 2025-10-28 | $139.50M 10-Q · filed 2025-10-28 | $180.03M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $46.86M 10-Q · filed 2025-07-29 | $90.39M 10-Q · filed 2025-07-29 | $130.93M derived: sum of 3 quarters · filed 2026-04-28 | $177.33M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $43.53M 10-Q · filed 2026-04-28 | $84.06M derived: sum of 2 quarters · filed 2026-04-28 | $130.46M derived: sum of 3 quarters · filed 2026-04-28 | $172.86M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $40.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $86.93M derived: sum of 2 quarters · filed 2026-02-24 | $129.33M derived: sum of 3 quarters · filed 2026-02-24 | $168.01M 10-K · filed 2026-02-24 |
| 2024-09-30 | $46.40M 10-Q · filed 2025-10-28 | $88.79M derived: sum of 2 quarters · filed 2025-10-28 | $127.48M 10-Q · filed 2025-10-28 | $164.22M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $42.40M 10-Q · filed 2025-07-29 | $81.08M 10-Q · filed 2025-07-29 | $117.82M derived: sum of 3 quarters · filed 2026-02-24 | $152.28M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $38.68M 10-Q · filed 2025-04-29 | $75.42M derived: sum of 2 quarters · filed 2026-02-24 | $109.89M derived: sum of 3 quarters · filed 2026-02-24 | $139.06M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $36.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $71.21M derived: sum of 2 quarters · filed 2026-02-24 | $100.38M derived: sum of 3 quarters · filed 2026-02-24 | $129.43M 10-K · filed 2026-02-24 |
| 2023-09-30 | $34.47M 10-Q · filed 2024-10-29 | $63.64M derived: sum of 2 quarters · filed 2024-10-29 | $92.69M 10-Q · filed 2024-10-29 | $119.90M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $29.18M 10-Q · filed 2024-07-25 | $58.22M 10-Q · filed 2024-07-25 | $85.44M derived: sum of 3 quarters · filed 2025-02-25 | $110.11M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $29.05M 10-Q · filed 2024-04-25 | $56.26M derived: sum of 2 quarters · filed 2025-02-25 | $80.94M derived: sum of 3 quarters · filed 2025-02-25 | $104.78M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $27.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $51.89M derived: sum of 2 quarters · filed 2025-02-25 | $75.73M derived: sum of 3 quarters · filed 2025-02-25 | $97.95M 10-K · filed 2025-02-25 |
| 2022-09-30 | $24.68M 10-Q · filed 2023-11-02 | $48.52M derived: sum of 2 quarters · filed 2023-11-02 | $70.74M 10-Q · filed 2023-11-02 | $93.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $23.84M 10-Q · filed 2023-08-01 | $46.06M 10-Q · filed 2023-08-01 | $68.80M derived: sum of 3 quarters · filed 2024-02-28 | $89.56M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $22.22M 10-Q · filed 2023-05-04 | $44.96M derived: sum of 2 quarters · filed 2024-02-28 | $65.72M derived: sum of 3 quarters · filed 2024-02-28 | $87.57M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $22.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $43.50M derived: sum of 2 quarters · filed 2024-02-28 | $65.35M derived: sum of 3 quarters · filed 2024-02-28 | $85.95M 10-K · filed 2024-02-28 |
| 2021-09-30 | $20.76M 10-Q · filed 2022-11-03 | $42.61M derived: sum of 2 quarters · filed 2022-11-03 | $63.21M 10-Q · filed 2022-11-03 | $78.71M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $21.85M 10-Q · filed 2022-08-04 | $42.45M 10-Q · filed 2022-08-04 | $57.95M derived: sum of 3 quarters · filed 2023-03-02 | $69.75M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $20.60M 10-Q · filed 2022-05-05 | $36.10M derived: sum of 2 quarters · filed 2023-03-02 | $47.90M derived: sum of 3 quarters · filed 2023-03-02 | $57.44M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $27.30M derived: sum of 2 quarters · filed 2023-03-02 | $36.84M derived: sum of 3 quarters · filed 2023-03-02 | $45.32M 10-K · filed 2023-03-02 |
| 2020-09-30 | $11.80M 10-Q · filed 2021-11-04 | $21.34M derived: sum of 2 quarters · filed 2021-11-04 | $29.82M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $9.54M 10-Q · filed 2021-08-05 | $18.02M 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | $34.96M 10-K · filed 2022-02-24 |